Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer

NCT02662062 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Cisplatin
RADIATION: Radiotherapy

Sponsor

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Collaborators

[object Object]